Pancreatic Cancer Research

ResearcherUniversidade de Santiago de CompostelaActive in the last 2 years

Miguel Pereira‐Silva

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4276-5063; OpenAlex author ID A5042441443. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2023: 1 paper · 2024: 2 papers · 2025: 2 papers · 2026: 1 paper

Papers 6

  1. Corrigendum to "Cancer cell membrane-modified Soluplus® micelles for gemcitabine delivery to pancreatic cancer using a prodrug approach" [Int. J. Pharm. 662 (2… Co-author DOI 10.1016/j.ijpharm.2026.127439↗
  2. Biomimetic nanosystems for pancreatic cancer therapy: A review. Co-author DOI 10.1016/j.jconrel.2025.113824↗
  3. Biomimetic cancer cell membrane-enriched vitamin E-stapled gemcitabine-loaded TPGS micelles for pancreatic cancer therapy. Co-author DOI 10.1080/10717544.2025.2527759↗
  4. Cancer cell membrane-modified Soluplus® micelles for gemcitabine delivery to pancreatic cancer using a prodrug approach. Co-author DOI 10.1016/j.ijpharm.2024.124529↗
  5. Gemcitabine-Vitamin E Prodrug-Loaded Micelles for Pancreatic Cancer Therapy. Co-author DOI 10.3390/pharmaceutics16010095↗
  6. Liposome-based diagnostic and therapeutic applications for pancreatic cancer. Co-author DOI 10.1016/j.actbio.2022.12.013↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ana Cláudia Paiva‐Santos · 6 shared papers, 2023–2026 · strength 1.55
  2. Carmen Alvarez‐Lorenzo · 5 shared papers, 2024–2026 · strength 1.38
  3. Bárbara Blanco‐Fernandez · 3 shared papers, 2024–2026 · strength 0.83
  4. Faisal Raza · 1 shared paper, 2023 · strength 0.17
  5. Diana Peixoto · 1 shared paper, 2023 · strength 0.17
  6. Clare Hoskins · 1 shared paper, 2023 · strength 0.17
  7. Abbas Rahdar · 1 shared paper, 2023 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.